Apparent central nervous system depression in infants after the use of topical brimonidine.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 10458196.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To report two cases in which topical brimonidine resulted in apparent central nervous system depression and unresponsiveness in an infant. Review of two patients. An 11-day-old infant became lethargic and apneic after a single drop of brimonidine. These symptoms were reproduced after a second administration of brimonidine. A 5-month-old infant became lethargic and poorly responsive after receiving 1 drop of brimonidine in each eye. The first patient required admission to the hospital for medical stabilization. He recovered without sequelae. The second patient recovered spontaneously approximately 2.5 hours after administration of brimonidine. Topical brimonidine may be associated with central nervous system depression in infants. The use of brimonidine is not recommended in these patients until further data are available.
Medical subject headings
- Adrenergic alpha-Agonists
- Central Nervous System
- Nervous System Diseases
- Quinoxalines